Primary Focal Segmental Glomerulosclerosis (FSGS)
1 clinical trials · Condition
◉ Watch Primary Focal Segmental Glomerulosclerosis (FSGS)
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients (NCT02921789) | Astellas Pharma Global Development, Inc. | 2017-05-22 |
Track Primary Focal Segmental Glomerulosclerosis (FSGS) automatically
Every clearance here is in the API, with alerts when new ones post.